Furthermore, we found that HNSCC cells harboring PIK3CA mutations are particularly susceptible to undergo apoptosis upon mTOR and ERK inhibition, thus providing a new therapeutic option for PIK3CA+ HNSCC patients. The gene discussed is MTOR; the disease is head and neck squamous cell carcinoma.